Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Bio-Gene Technology Ltd. ( (AU:BGT) ) is now available.
Bio-Gene Technology Ltd. has announced significant progress in the development of two new insecticidal compounds, Flavocide® and Qcide®, which utilize novel modes of action derived from a unique sub-type of eucalypt. These insecticides are effective against pests resistant to standard products and target a substantial total addressable market of $31 billion. Furthermore, the company has formed strategic partnerships with Clarke Mosquito, Evergreen Garden Care, and STK to enhance their market reach across various regions.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Ltd. operates in the biotechnology industry, focusing on the development of innovative insecticides derived from natural sources. Their primary products include two insecticidal compounds, Flavocide® and Qcide®, which target a broad range of markets such as crop protection, public health, consumer applications, and animal health. The company is strategically positioned to address the increasing demand for environmentally friendly pest control solutions.
YTD Price Performance: 13.95%
Average Trading Volume: 982,820
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$9.87M
Find detailed analytics on BGT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue